Former FDA No. 2 Amy Abernethy rejoins Robert Califf at Google's Verily, hopping aboard as clinical R&D head
Google’s life sciences company Verily on Thursday tapped former principal deputy FDA commissioner Amy Abernethy as president of its clinical research business.
The move means Abernethy, who left the FDA at the end of April, will join fellow FDA alum and former commissioner Robert Califf, who serves as head of Verily’s clinical policy and strategy. Both Abernethy and Califf also previously taught at Duke University.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,900+ biopharma pros reading Endpoints daily — and it's free.